Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	RÁČIL Zdeněk TOŠKOVÁ Martina DVOŘÁKOVÁ Dana JEŽÍŠKOVÁ Ivana RÁZGA Filip BUREŠOVÁ Lucie TIMILSINA Shira MAYER Jiří
Year of publication	2012
Type	Article in Periodical
Magazine / Source	American Journal of Hematology
MU Faculty or unit	Central European Institute of Technology
Citation
Web	http://onlinelibrary.wiley.com/doi/10.1002/ajh.22213/abstract
Doi	http://dx.doi.org/10.1002/ajh.22213
Field	Oncology and hematology
Keywords	molecular relapse; AML; clofarabine monotherapy
Description	Few studies have examined the treatment of molecular relapse in patients with acute myeloid leukemia (AML) using different treatment regimens. We describe for the first time in the literature experiences with administration of clofarabine monotherapy in the treatment of eight patients with AML with molecular relapse of the disease.
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies